Companies and researchers often fail to disclose negative trial results, resulting in significant gaps in the public record ...
The FDA has approved the NEXUS Aortic Arch Stent Graft enabling commercial launch of the NEXUS System in the US.
InVera Medical has received FDA 510 (k) clearance for the InVera Infusion Device, a new minimally invasive device designed to ...
Hologic announced the appointment of José (Joe) E. Almeida as Chief Executive Officer, effective immediately upon closing of the previously announced company acquisition. Hologic, Inc. announced the ...
Designed to expand treatment options for patients with cirrhosis and complications of portal hypertension, this ...
Allevion Medical Receives FDA Clearance for Vantage™, Introducing a Fully Disposable Approach to Minimally Invasive Spinal ...
New technology designed to provide a single irrigation management system for ureteroscopy, cystoscopy, percutaneous ...
New set of 73 Real World Evidence examples illustrate how RWD can support rigorous validation of novel device software ...
The acquisition expands Merit’s portfolio of therapeutic oncology products dedicated to the accurate diagnosis and localization of breast and soft tissue tumors.
In this part 2 of a 4-part series, Melissa highlight how the moment AI begins to influence decisions or workflows, it is ...
The company's River stent will be available for adults with severe IIH – a debilitating, historically undertreated condition ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results